Evidence map›Paper›PMID 25710922›Full record

Observational studyDiabetes care2015

Preventable major cardiovascular events associated with uncontrolled glucose, blood pressure, and lipids and active smoking in adults with diabetes with and without cardiovascular disease: a contemporary analysis.

Gabriela Vazquez-Benitez, Jay R Desai, Stanley Xu, Glenn K Goodrich, Emily B Schroeder, Gregory A Nichols, Jodi Segal, Melissa G Butler, Andrew J Karter, John F Steiner and 11 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Diabetes care, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 3 pooled it
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 3 syntheses or guidelines pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Phosphate and fibroblast growth factor 23 in diabetes.Clinical science (London, England : 1979) · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 10 institutions in 1 country.

Gabriela Vazquez-BenitezHealthPartners Institute for Education and Research, Minneapolis, MN gabriela.x.vazquezbenitez@healthpartners.com.
Jay R DesaiHealthPartners Institute for Education and Research, Minneapolis, MN.
Stanley XuKaiser Permanente Institute for Health Research, Denver, CO.
Glenn K GoodrichKaiser Permanente Institute for Health Research, Denver, CO.
Emily B SchroederKaiser Permanente Institute for Health Research, Denver, CO.
Gregory A NicholsKaiser Permanente Center for Health Research, Portland, OR.
Jodi SegalJohns Hopkins Medicine, Baltimore, MD.
Melissa G ButlerKaiser Permanente Georgia, Center for Health Research Southeast, Atlanta, GA.
Andrew J KarterDivision of Research, Kaiser Permanente Northern California, Oakland, CA.
John F SteinerKaiser Permanente Institute for Health Research, Denver, CO.
Katherine M NewtonGroup Health Research Institute, Seattle, WA.
Leo S MoralesUniversity of Washington School of Medicine, Seattle, WA.
Ram D PathakDepartment of Endocrinology, Marshfield Clinic, Marshfield, WI.
Abraham ThomasLutheran Medical Center, Brooklyn, NY.
Kristi ReynoldsDepartment of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA.
H Lester KirchnerGeisinger Health System, Danville, PA.
Beth WaitzfelderKaiser Permanente Center for Health Research, Honolulu, HI.
Jennifer Elston LafataLutheran Medical Center, Brooklyn, NY Virginia Commonwealth University School of Medicine, Richmond, VA.
Renuka AdibhatlaHealthPartners Institute for Education and Research, Minneapolis, MN.
Zhiyuan XuHealthPartners Institute for Education and Research, Minneapolis, MN.
Patrick J O'ConnorHealthPartners Institute for Education and Research, Minneapolis, MN.
Kaiser Permanente · USHealthPartners · USGeisinger Health System · USJohns Hopkins Medicine · USKaiser Permanente Center for Health Research · USKaiser Permanente Washington Health Research Institute · USLutheran Medical Center · USMarshfield Clinic · USUniversity of Washington · USVirginia Commonwealth University · US

Funding

Translational Research Core - Health Engagement & Action Translational (HEAT)P30DK092924 · NIDDK · KAISER FOUNDATION RESEARCH INSTITUTE · PI Alyce Sophia Adams, HILARY Kessler SELIGMAN · 2011 to 2026
$9.2M
Multi-institutional Consortium for CER in Diabetes Treatment and PreventionR01HS019859 · AHRQ · KAISER FOUNDATION RESEARCH INSTITUTE · PI STEINER, JOHN F · 2010 to 2010
$8.9M
AHRQ HHS R01 HS019859AHRQ HHS R01HS019859NIDDK NIH HHS P30 DK092924
6 · The paper itself

Abstract

objectiveThe objective of this study was to assess the incidence of major cardiovascular (CV) hospitalization events and all-cause deaths among adults with diabetes with or without CV disease (CVD) associated with inadequately controlled glycated hemoglobin (A1C), high LDL cholesterol (LDL-C), high blood pressure (BP), and current smoking. RESEARCH DESIGN AND

methodsStudy subjects included 859,617 adults with diabetes enrolled for more than 6 months during 2005-2011 in a network of 11 U.S. integrated health care organizations. Inadequate risk factor control was classified as LDL-C ≥100 mg/dL, A1C ≥7% (53 mmol/mol), BP ≥140/90 mm Hg, or smoking. Major CV events were based on primary hospital discharge diagnoses for myocardial infarction (MI) and acute coronary syndrome (ACS), stroke, or heart failure (HF). Five-year incidence rates, rate ratios, and average attributable fractions were estimated using multivariable Poisson regression models.

resultsMean (SD) age at baseline was 59 (14) years; 48% of subjects were female, 45% were white, and 31% had CVD. Mean follow-up was 59 months. Event rates per 100 person-years for adults with diabetes and CVD versus those without CVD were 6.0 vs. 1.7 for MI/ACS, 5.3 vs. 1.5 for stroke, 8.4 vs. 1.2 for HF, 18.1 vs. 40 for all CV events, and 23.5 vs. 5.0 for all-cause mortality. The percentages of CV events and deaths associated with inadequate risk factor control were 11% and 3%, respectively, for those with CVD and 34% and 7%, respectively, for those without CVD.

conclusionsAdditional attention to traditional CV risk factors could yield further substantive reductions in CV events and mortality in adults with diabetes.

Indexed as

AdultAgedAged, 80 and overBlood GlucoseBlood PressureBlood Pressure DeterminationCause of DeathCholesterol, LDLDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Diabetic AngiopathiesFemaleGlycated HemoglobinHeart FailureHospitalizationHumansBlood GlucoseCholesterol, LDLGlycated Hemoglobin

Identifiers

PMID25710922
PMCPMC4876667
OpenAlexW2028488250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.